$171.00 Original price was: $171.00.$21.00Current price is: $21.00.
Authored by renowned expert David A. Gewirtz, this volume in the Advances in Cancer Research series delves into the latest strategies to mitigate the toxicity of cancer therapeutics. This book is a must-have for researchers, oncologists, and medical professionals seeking to enhance their understanding of cutting-edge treatments and their potential side effects.
Featuring contributions from an international board of authors, this publication offers a diverse range of perspectives and expertise. Each chapter provides in-depth analysis and practical advice on mitigating the toxicity of various cancer treatments, making it an invaluable resource for those working in the field of oncology.
Volume 155 in the Advances in Cancer Research series is dedicated to exploring the most recent developments in cancer treatment toxicity mitigation. Covering a broad spectrum of topics, this book ensures that readers are up-to-date with the latest research findings and their implications for patient care.
Written with both researchers and practitioners in mind, this book strikes a balance between technical detail and readability. It provides a comprehensive overview of current strategies to mitigate the toxicity of cancer therapeutics, making it an essential reference for anyone involved in cancer treatment and research.
Published by Elsevier Science in June 2022, this book is a vital addition to any medical or research library. It offers a wealth of knowledge and practical advice for those working to improve patient outcomes in the field of oncology.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline